/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Cohealo Surpasses 2,500 Shares of Medical Equipment for Health System Partners
BOSTON–(BUSINESS WIRE)–Cohealo, a platform for health systems to track and share medical
equipment, marked a significant milestone this month when it facilitated
its 2500th share of equipment between its clients’ hospitals.
Health systems spend $45 billion per year on perioperative equipment
that often sits idle for up to 90% of its useful life. Shared equipment
enables hospitals to avoid expensive equipment rentals and decreases the
need to purchase multiple units of the same equipment.
At HIMSS19, Dr. Ronald Loo of Kaiser Permanente Medical Group presented
their two-year savings outcomes from sharing equipment in Southern
California, which have totaled more than $8 million. “Sharing equipment
is a win-win for Kaiser Permanente. Patients win, because we can provide
them with the highest quality of care at the most affordable price, and
our surgeons win by gaining access to newer equipment, faster.”
There is a clarion call for hospitals to identify unique opportunities
for savings as never before. Evolving regulations, fluctuations in the
economy, and changing expectations around patient care are adversely
impacting hospital operating margins, which have fallen to a low of
1.6%. Hospitals are closing at a rate of 30 per year, leaving patients
in rural areas vulnerable.
“The sharing economy has empowered thousands of consumers to tap into
the excess capacity of their cars and homes, delivering value from idle
resources. Sharing medical equipment is an eight-figure per year savings
opportunity for health systems,” said Cohealo’s chief executive officer,
Todd Rothenhaus, M.D. “Our 2500th equipment share
demonstrates that collaborative equipment management can be accomplished
at scale, without asset damage or disruption to clinical workflows.”
Medical equipment is one of the largest expenses for health systems. A
single piece of perioperative equipment can cost more than $500,000.
However, that equipment is typically only used at the facility for which
it was purchased, limiting the potential for return on investment. With
a single equipment share, Cohealo has impacted as many as 62 cases at
the borrowing site, providing a cost-effective alternative to buying new
equipment.
About Cohealo
Based in Boston, Cohealo finds savings for health systems by increasing
the utilization of their medical equipment through proactive data
analytics and equipment sharing. With deeper insights into equipment
usage, hospitals can pinpoint redundant equipment, opportunities for
rental avoidance, and ways to share equipment between facilities. As the
program scales within a health system, the network effect drives
increasing levels of savings by reducing redundant purchases and
decreasing rental expense. Cohealo has been named to Fast Company’s Most
Innovative Companies List and CNBC’s Disruptor 50 and is recognized as
the first solution of its type to bring the sharing economy to
healthcare. To learn more about Cohealo, visit www.cohealo.com.
Contacts
Danielle Goldschneider
Senior Product Marketing Manager
857-383-6047
[email protected]
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Humboldt
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia
SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.
The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.
Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.
“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”
Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”
About Humboldt Seed Company
Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.
For more information visit https://humboldtseedcompany.com/.
About Apollo Green
Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics.
For more information visit https://apollogreen.com/.
Media contact
Jaana Prall
[email protected]
Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Innocan2 weeks ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf2 weeks ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis2 weeks ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE4 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis4 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt4 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
Cannabis4 days ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical